The END Fund
The END Fund is a philanthropic nonprofit focussed on ending neglected tropical diseases (NTDs). The US-based fund, established by Legatum Foundation in 2012, utilises private capital to invest in sustainable programmes tackling NTDs .
- Organisation type Corporate giving
- Year founded 2012
- Headquartered New York
- Registration United States
- Website https://www.end.org
Related sustainable development goals
Impact
1.5b+ people treated
US$ 2.3b+ value of treatments
5m+ health workers trained
Focus areas
Focus sectors
Health
- Diseases and conditions
- Infectious and parasitic diseases
Philanthropy
- Foundations
- Nonprofits
- Venture philanthropy
Focus populations
- Low-income people
Focus geographies
Africa
- Cote d'Ivoire
- Zimbabwe
- Mali
- Congo R
- Madagascar
- Kenya
- Burundi
- Central African Republic
- Liberia
- Rwanda
- Tanzania
- Sudan
- Somalia
- Eritrea
- South Sudan
- Mauritania
- Zambia
- Niger
- DR Congo
- Senegal
- Nigeria
- Chad
- Namibia
- Angola
- Ethiopia
Middle East
- Yemen
South Asia
- India
- Afghanistan
Grantees
- World Food Programme (WFP)
- World Health Organisation
Partners
- GLIDE
- Reaching the Last Mile
- WHO
Programmes
Deworming Innovation Fund
This programme works on eliminating health burdens caused by paracitic worm infections - intestinal worms and schistosomiasis.
Flagship Fund
Provides access to treatment for five top NTDs.
Reaching the Last Mile Fund
Aims to eliminate river blindness and lymphatic filariasis (LF).
Financials
Details
- US$ 45,000,000 annual spend
Funding model
- Programme related investment
Primary funders
- Al Ansari Exchange
- Astellas Global Health Foundation
- Bill & Melinda Gates Foundation
- Cambell Family Foundation
- Children's Investment Fund Foundation
- Delta Philanthropies
- Dubai Cares
- Good Ventures
- Jackson Kemper Foundation
- Jeffrey and Marieke Rothschild
- Latter Day Saints
- Legatum Group
- Mackenzie Scott
- Margaret A. Cargill Philanthropies
- MSD Foundation
- Shefa Fund
- Sint Antonius Stichting Projecten
- The Elma Foundation
- The Leona M. and Harry B. Helmsley Charitable Trust
- The Moondance Foundation
- UAE Presidential Court
- UBS Optimus Foundation
- UK AID
- Virgin Unite
- Wyss Medical Foundation
Funding source
- Pooled fund
Operations
Key staff
- Ellen Agler, CEO
Board members
- Tsitsi Masiyiwa, chair
- Kesetebirhan (Kesete) Admasu
- Robyn Calder
- Michael P. Hoffman
- Faustina Fynn-Nyame
- Alan McCormick
- Christine Wächter-Campbell
- Moses Bockarie
- Temitope Lawani
- Scott Powell
- English Sall
- William I. Campbell
- Katey Owen
Contact details
- 00 1 646 690 9775
- info@end.org
- https://www.end.org
- 2 Park Avenue, 28th Floor, New York, NY 10016, USA
More
Resources
Op-ed: CEO of the END Fund, Ellen Agler, talks about patient philanthropy and the importance of understanding systems before trying to change them. Read more
Podcast: In this podcast episode of Philanthropy Age's The Impact Room, Agler talks to host Maysa Jalbout about the challenges of last-mile disease elimination. Listen to the episode here
Reframing Neglect: The END Fund commissioned a photography show by seven African artists who showcase images depicting the harsh reality and disproportional impact of neglected tropic diseases (NTDs). Read more